308 related articles for article (PubMed ID: 17514734)
21. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; Stigter RL; van Wering ER; Janka-Schaub GE; Slater R; Pieters R
Blood; 2003 Apr; 101(7):2743-7. PubMed ID: 12433682
[TBL] [Abstract][Full Text] [Related]
22. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
Lorenzi PL; Reinhold WC; Rudelius M; Gunsior M; Shankavaram U; Bussey KJ; Scherf U; Eichler GS; Martin SE; Chin K; Gray JW; Kohn EC; Horak ID; Von Hoff DD; Raffeld M; Goldsmith PK; Caplen NJ; Weinstein JN
Mol Cancer Ther; 2006 Nov; 5(11):2613-23. PubMed ID: 17088436
[TBL] [Abstract][Full Text] [Related]
23. Investigating the gut microbial community and genes in children with differing levels of change in serum asparaginase activity during pegaspargase treatment for acute lymphoblastic leukemia.
Dunn KA; Connors J; Bielawski JP; Nearing JT; Langille MGI; Van Limbergen J; Fernandez CV; MacDonald T; Kulkarni K
Leuk Lymphoma; 2021 Apr; 62(4):927-936. PubMed ID: 33258724
[TBL] [Abstract][Full Text] [Related]
24. Asparagine synthetase chemotherapy.
Richards NG; Kilberg MS
Annu Rev Biochem; 2006; 75():629-54. PubMed ID: 16756505
[TBL] [Abstract][Full Text] [Related]
25. Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL.
Akahane K; Kimura S; Miyake K; Watanabe A; Kagami K; Yoshimura K; Shinohara T; Harama D; Kasai S; Goi K; Kawai T; Hata K; Kiyokawa N; Koh K; Imamura T; Horibe K; Look AT; Minegishi M; Sugita K; Takita J; Inukai T
Blood Adv; 2022 Jan; 6(1):212-224. PubMed ID: 34535013
[TBL] [Abstract][Full Text] [Related]
26. A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells.
Ikeuchi H; Ahn YM; Otokawa T; Watanabe B; Hegazy L; Hiratake J; Richards NG
Bioorg Med Chem; 2012 Oct; 20(19):5915-27. PubMed ID: 22951255
[TBL] [Abstract][Full Text] [Related]
27. Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature.
Serravalle S; Bertuccio SN; Astolfi A; Melchionda F; Pession A
Biomed Res Int; 2016; 2016():1985750. PubMed ID: 28003999
[TBL] [Abstract][Full Text] [Related]
28. Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia.
Bushman JE; Palmieri D; Whinna HC; Church FC
Leuk Res; 2000 Jul; 24(7):559-65. PubMed ID: 10867129
[TBL] [Abstract][Full Text] [Related]
29. Selective apoptosis of natural killer-cell tumours by l-asparaginase.
Ando M; Sugimoto K; Kitoh T; Sasaki M; Mukai K; Ando J; Egashira M; Schuster SM; Oshimi K
Br J Haematol; 2005 Sep; 130(6):860-8. PubMed ID: 16156856
[TBL] [Abstract][Full Text] [Related]
30. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.
Chan WK; Lorenzi PL; Anishkin A; Purwaha P; Rogers DM; Sukharev S; Rempe SB; Weinstein JN
Blood; 2014 Jun; 123(23):3596-606. PubMed ID: 24659632
[TBL] [Abstract][Full Text] [Related]
31. Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.
Watanabe A; Miyake K; Nordlund J; Syvänen AC; van der Weyden L; Honda H; Yamasaki N; Nagamachi A; Inaba T; Ikawa T; Urayama KY; Kiyokawa N; Ohara A; Kimura S; Kubota Y; Takita J; Goto H; Sakaguchi K; Minegishi M; Iwamoto S; Shinohara T; Kagami K; Abe M; Akahane K; Goi K; Sugita K; Inukai T
Blood; 2020 Nov; 136(20):2319-2333. PubMed ID: 32573712
[TBL] [Abstract][Full Text] [Related]
32. Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.
Zhang B; Dong LW; Tan YX; Zhang J; Pan YF; Yang C; Li MH; Ding ZW; Liu LJ; Jiang TY; Yang JH; Wang HY
Br J Cancer; 2013 Jul; 109(1):14-23. PubMed ID: 23764751
[TBL] [Abstract][Full Text] [Related]
33. Cathepsin B Is Not an Intrinsic Factor Related to Asparaginase Resistance of the Acute Lymphoblastic Leukemia REH Cell Line.
Costa IM; Effer B; Costa-Silva TA; Chen C; Ciccone MF; Pessoa A; Dos Santos CO; Monteiro G
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446393
[TBL] [Abstract][Full Text] [Related]
34. Influence of genetic variants in asparaginase pathway on the susceptibility to asparaginase-related toxicity and patients' outcome in childhood acute lymphoblastic leukemia.
Youssef YH; Makkeyah SM; Soliman AF; Meky NH
Cancer Chemother Pharmacol; 2021 Aug; 88(2):313-321. PubMed ID: 33959786
[TBL] [Abstract][Full Text] [Related]
35. Declined asparagine synthetase mRNA expression and enhanced sensitivity to asparaginase in HL-60 cells committed to monocytic differentiation.
Hashimoto K; Suzuki F; Sakagami H
Anticancer Res; 2009 Apr; 29(4):1303-8. PubMed ID: 19414379
[TBL] [Abstract][Full Text] [Related]
36. Asparagine synthetase (ASNS) gene polymorphism is associated with the outcome of childhood acute lymphoblastic leukemia by affecting early response to treatment.
Pastorczak A; Fendler W; Zalewska-Szewczyk B; Górniak P; Lejman M; Trelińska J; Walenciak J; Kowalczyk J; Szczepanski T; Mlynarski W;
Leuk Res; 2014 Feb; 38(2):180-3. PubMed ID: 24268318
[TBL] [Abstract][Full Text] [Related]
37. Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells.
Nishikawa G; Kawada K; Hanada K; Maekawa H; Itatani Y; Miyoshi H; Taketo MM; Obama K
Cells; 2022 Oct; 11(20):. PubMed ID: 36291140
[TBL] [Abstract][Full Text] [Related]
38. Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).
Jarrar M; Gaynon PS; Periclou AP; Fu C; Harris RE; Stram D; Altman A; Bostrom B; Breneman J; Steele D; Trigg M; Zipf T; Avramis VI
Pediatr Blood Cancer; 2006 Aug; 47(2):141-6. PubMed ID: 16425271
[TBL] [Abstract][Full Text] [Related]
39. Asparagine synthetase is partially localized to the plasma membrane and upregulated by L-asparaginase in U937 cells.
He Y; Li B; Luo C; Shen S; Chen J; Xue H; Tang J; Gu L
J Huazhong Univ Sci Technolog Med Sci; 2011 Apr; 31(2):159-163. PubMed ID: 21505976
[TBL] [Abstract][Full Text] [Related]
40. Asparagine Synthetase Is Highly Expressed at Baseline in the Pancreas Through Heightened PERK Signaling.
Mukherjee A; Ahmed N; Rose FT; Ahmad AN; Javed TA; Wen L; Bottino R; Xiao X; Kilberg MS; Husain SZ
Cell Mol Gastroenterol Hepatol; 2020; 9(1):1-13. PubMed ID: 31421261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
